We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$867B
AUM Growth
-$1.1B
Cap. Flow
-$19.5B
Cap. Flow %
-2.25%
Top 10 Hldgs %
35.42%
Holding
3,110
New
92
Increased
1,805
Reduced
946
Closed
96

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$2.81B
2
BA icon
Boeing
BA
+$1.68B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.33B
4
APH icon
Amphenol
APH
+$1.11B
5
CME icon
CME Group
CME
+$902M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.65B
2
AMD icon
Advanced Micro Devices
AMD
+$2.51B
3
UNH icon
UnitedHealth
UNH
+$2.06B
4
UBER icon
Uber
UBER
+$1.84B
5
ADBE icon
Adobe
ADBE
+$1.44B

Sector Composition

Rank Sector Weight
1 Technology 33.21%
2 Healthcare 12.77%
3 Consumer Discretionary 11.71%
4 Financials 11.15%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STI icon
2976
Solidion Technology
STI
$55.5M
$22K ﹤0.01%
+632
New +$13.1K
HLVX
2977
DELISTED
HilleVax
HLVX
$21K ﹤0.01%
10,063
– –
NOTE
2978
DELISTED
FiscalNote
NOTE
$21K ﹤0.01%
1,633
– –
SMXT icon
2979
Solarmax Technology
SMXT
$11M
$21K ﹤0.01%
+1,076
New +$15.4K
BNGO icon
2980
Bionano Genomics
BNGO
$19.5M
$20K ﹤0.01%
1,173
– –
GORO icon
2981
Goldgroup Mining
GORO
$475M
$20K ﹤0.01%
21,175
– –
WKHS icon
2982
Workhorse Group
WKHS
$31.4M
$20K ﹤0.01%
192
– –
ALXO icon
2983
ALX Oncology
ALXO
$181M
$18K ﹤0.01%
10,622
– –
OVID icon
2984
Ovid Therapeutics
OVID
$469M
$17K ﹤0.01%
17,396
– –
IPSC icon
2985
Century Therapeutics
IPSC
$302M
$16K ﹤0.01%
14,882
– –
SCWO icon
2986
374Water
SCWO
$53.3M
$16K ﹤0.01%
2,263
– –
SST icon
2987
System1
SST
$24.6M
$16K ﹤0.01%
1,760
– –
STTK icon
2988
Shattuck Labs
STTK
$609M
$16K ﹤0.01%
12,603
-19,300
-60% -$23.9K
SBDS
2989
DELISTED
Solo Brands Inc
SBDS
$16K ﹤0.01%
333
+31
+10% +$1.54K
PRPH
2990
DELISTED
ProPhase Labs
PRPH
$13K ﹤0.01%
1,730
– –
IVVD icon
2991
Invivyd
IVVD
$275M
$12K ﹤0.01%
25,760
– –
DRRX
2992
DELISTED
DURECT Corp
DRRX
$11K ﹤0.01%
14,210
– –
ELEV
2993
DELISTED
Elevation Oncology
ELEV
$10K ﹤0.01%
16,841
– –
QSR icon
2994
Restaurant Brands International
QSR
$25B
$10K ﹤0.01%
+150
New +$10.4K
MKTW icon
2995
MarketWise
MKTW
$56.8M
$9K ﹤0.01%
802
– –
GCTS.WS
2996
GCT Semiconductor Holding Warrants
GCTS.WS
$15M
$5K ﹤0.01%
37,675
– –
LYRA
2997
DELISTED
LYRA THERAPEUTICS INC
LYRA
$4K ﹤0.01%
351
– –
VSTEW
2998
DELISTED
Vast Renewables Limited Warrants
VSTEW
$3K ﹤0.01%
38,375
– –
SRZNW
2999
DELISTED
Surrozen Inc Warrant
SRZNW
$1K ﹤0.01%
41,666
– –
AGEN
3000
Agenus
AGEN
$386M
– –
-21,072
Closed -$116K

Similar funds

T. Rowe Price Associates's Q4 2024 Portfolio in Review

As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
  • T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
  • T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
  • T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
  • T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
  • T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
  • T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.

Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.